About   Help   FAQ
Phenotype Image Detail
Image
Caption Brca2tm1Brn/Brca2tm1Brn Trp53tm1Brn/Trp53tm1BrnTg(Pbsn-cre)4Prb/0 (Brca2F/F;Trp53F/F;PBCre4) prostates have hallmarks of cancer. (A) Ki-67 immunohistochemistry shows increased proliferation in areas of low-grade prostate intraepithelial neoplasia (LG PIN) in Brca2tm1Brn/Brca2tm1Brn Tg(Pbsn-cre)4Prb/0 (Brca2F/F;PBCre4) and Brca2tm1Brn/Brca2tm1Brn Trp53tm1Brn/Trp53+ Tg(Pbsn-cre)4Prb/0 (Brca2F/F;Trp53F/+;PBCre4) prostates, a low number of proliferating cells are present in control (Brca2F/F) prostates. Brca2tm1Brn/Brca2tm1Brn Trp53tm1Brn/Trp53tm1Brn Tg(Pbsn-cre)4Prb/0 mutants have a large number of proliferating cells in areas of high-grade (HG) PIN. (B) Androgen receptor (AR) immunohistochemistry demonstrating increased levels of expression throughout the nucleus and cytoplasm in areas of LG PIN in Brca2tm1Brn/Brca2tm1Brn Tg(Pbsn-cre)4Prb/0 and Brca2tm1Brn/Brca2tm1Brn Trp53tm1Brn/Trp53+ Tg(Pbsn-cre)4Prb/0 prostates, compared to control prostates. Brca2tm1Brn/Brca2tm1Brn Trp53tm1Brn/Trp53tm1Brn Tg(Pbsn-cre)4Prb/0 have increased AR expression predominantly in the nucleus of cells in areas of HG PIN. (C) p63 immunohistochemistry shows an increase in p63-expressing cells in HG PIN lesions in Brca2tm1Brn/Brca2tm1Brn Trp53tm1Brn/Trp53tm1Brn Tg(Pbsn-cre)4Prb/0 prostates and normal expression in the basal cells of control (Brca2F/F;Trp53F/F) prostates. Arrows indicate a cluster of abnormal p63-expressing cells that are rounder and nearer the lumen. (D) Panel shows p63 (red) and CK5 (green) fluorescent immunohistochemistry analysis with labelled cells protruding into the lumen (white arrowheads) in a region of PIN in Brca2tm1Brn/Brca2tm1Brn Trp53tm1Brn/Trp53tm1Brn Tg(Pbsn-cre)4Prb/0 mutants. (E) Panel shows CK5 (green, basal cells) and CK8 (red, luminal cells) fluorescent immunohistochemistry with PIN lesions in Brca2tm1Brn/Brca2tm1Brn Trp53tm1Brn/Trp53tm1Brn Tg(Pbsn-cre)4Prb/0 mutants displaying an increase in luminal cells next to clusters of basal cells. White arrowhead marks CK5 and CK8 double-labelled cells. DAPI nuclear stain is blue. The anterior prostates of 16-month-old animals are shown.
Copyright This image is from Francis JC, PLoS Genet 2010;6(6):e1000995, and is displayed under the terms of the Creative Commons Attribution 4.0 International License. J:161511
Associated
Alleles
Symbol Name
Brca2tm1Brn breast cancer 2, early onset; targeted mutation 1, Anton Berns
Tg(Pbsn-cre)4Prb transgene insertion 4, Pradip Roy-Burman
Trp53tm1Brn transformation related protein 53; targeted mutation 1, Anton Berns
Associated
Genotypes
Allelic Composition Genetic Background
Brca2tm1Brn/Brca2tm1Brn
Tg(Pbsn-cre)4Prb/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Brn/Trp53tm1Brn
Tg(Pbsn-cre)4Prb/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2
Brca2tm1Brn/Brca2tm1Brn
Trp53tm1Brn/Trp53+
Tg(Pbsn-cre)4Prb/0
involves: 129P2/OlaHsd * C57BL/6 * DBA/2

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/05/2024
MGI 6.24
The Jackson Laboratory